|
Sent: Wednesday, April 25, 2001
6:57 AM
Subject: Two Article from The World of Multiple Sclerosis
Posting of the following article has been approved by The
World of
Multiple Sclerosis http://www.ifmss.org.uk/default.htm
---US Buffalo University Team Uses
DNA Microarray Method Against MS---
A multidisciplinary team of pharmaceutics and computer-science
researchers
at the University at Buffalo, one of very few teams in the nation
applying
DNA microarray technology in studies of multiple sclerosis (MS),
has
developed a method of interpreting the massive amount of information
that
results from such experiments.
The application of this method to genomic data could help researchers
in the
UB School of Pharmacy and Pharmaceutical Sciences, the School
of Medicine
and Biomedical Sciences and Buffalo General Hospital to develop
and
ultimately predict the best treatment strategies for MS patients
based on
levels of gene expression, the process by which a gene's coded
information
is converted into, or expressed, as proteins in cells.
http://www.msif.org/newpwms/Research/default.asp?ID=91
--------------------------------------------------------------------------
---Society-Sponsored Task Force Develops
Guidelines For Use Of Placebos In
Clinical Trials For MS---
An international task force convened by the US National MS
Society has
developed guidelines for the use of inactive placebos in future
clinical
trials for MS. With the availability of agents for treating of
MS, questions
have been raised about the practicality and ethics of future
trials that
might include a placebo-treated group. The task force, chaired
by Fred D.
Lublin, MD (Mount Sinai School of Medicine, New York City), reports
these
guidelines in the May issue of the Annals of Neurology.
http://www.msif.org/newpwms/Research/default.asp?ID=87
|
